Analyst initiations: AXA, BSCI, BSX, and MDT
Posted Aug 24th 2007 11:26AM by Kevin Shult
Filed under: Before the bell, Analyst reports, Boston Scientific (BSX), Analyst initiations, Stocks to Buy, Stocks to Sell
MOST NOTEWORTHY: Boston Scientific (BSX), Medtronic (MDT), St. Jude Medical (STJ), Bankrate (RATE) and AXA (AXA) were today's noteworthy initiations:
- Thomas Wiesel initiated coverage of the Medical Devices Industry:
- Boston Scientific (NYSE: BSX) was initiated with an Underweight rating, expecting shares to Underperform peers due to reductions in estimates, risks to the stent business and valuation.
- Medtronic (NYSE: MDT) was initiated with an Overweight rating, saying attractively valued as they believe the growth in underlying markets may be more robust than the current sentiment suggests.
- St. Jude Medical (NYSE: SJT) was initiated with an Overweight rating, saying shares offer exposure to attractive drivers, a management team with the best track record in the segment, and a potential acquisition candidate.
- Stephens believes the recent weakness in Bankrate (NASDAQ: RATE) due to "turmoil" in the market has created an attractive entry point, starting shares with an Overweight rating.
- Morgan Stanley assumed coverage of AXA (NYSE: AXA) with an Overweight rating, citing an attractive risk/reward and strong free cash flow...
OTHER INITIATIONS:
- S1 Corp (NASDAQ: SONE) was initiated with a Market Perform rating at Avondale.
- Credit Suisse initiated AK Steel (NYSE: AKS) with a Neutral rating.
- Jefferies started Molex (NASDAQ: MOLX) with a Hold rating.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required). Tags: ak steel, aks, AkSteel, analyst, axa, bankrate, blue coat, BlueCoat, boston scientific, BostonScientific, bsx, initiation, medtronic, molex, molx, rate, rating, s1, sone, st jude, stj, StJude
Reader Comments (Page 1 of 1)
9-05-2007 @ 11:16PM
Ken said...
Be careful of Morgan Stanley's coverage of AXA. There are officers of both companies in bed together.